Inactive Instrument

Press Releases Diamyd Medical AB Swiss Exchange

Equities

SE0005162880

End-of-day quote Swiss Exchange Other stock markets
- ^SEK	-

05-16	Diamyd Medical AB Updates on the Registrational Phase 3 Trial	CI
04-18	Diamyd Medical Raises SEK57 Million in Rights Issue	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Diamyd Medical updates on the registrational Phase 3 trial; upcoming interim analysis and enrollment	05-16	AQ
Diamyd Medical announces final outcome in the company's rights issue	04-18	AQ
Diamyd Medical announces preliminary outcome in the company's rights issue	04-16	AQ
Recruitment milestone reached in Diamyd® Phase 3 trial	04-12	AQ
Diamyd Medical led ASSET innovation partnership organizes a workshop on the future treatment of Type 1 Diabetes	04-11	AQ
Diamyd Medical's main Shareholders announce their subscription commitments in the ongoing rights issue	04-05	AQ
Diamyd Medical publishes prospectus with regards to the rights issue	03-28	AQ
Quarterly Report II 23/24	03-27	AQ
The Board of Directors in Diamyd Medical have resolved on a rights issue of approximately SEK 114 million	03-18	AQ
Diamyd Medical to present new genetic data at the ASIT summit in Boston, MA	02-29	AQ
Diamyd Medical receives U.S. FDA Fast Track designation for Diamyd®	02-15	AQ
Publication in Diabetologia highlights AI's potential for Type 1 Diabetes screening	02-14	AQ
In-depth analysis of Diamyd® Phase II trial further supports value of preserved insulin secretion	01-24	AQ
Quarterly Report I 23/24	01-24	AQ
Diamyd Medical gains market research findings to guide U.S. commercial strategy	01-08	AQ
Diamyd® precision medicine Phase 3 trial key interim analysis in July	01-04	AQ
Diamyd Medical's Precision Medicine patent for the prevention and treatment of autoimmune diabetes granted in South Korea	12-06	AQ
Bulletin from Annual General Meeting of Diamyd Medical AB	11-30	AQ
Annual Report 2022/2023	11-29	AQ
Type 1 Diabetes Pipeline\| Clinical Trials and Key Companies - Landos Biopharma, Diamyd Medical, Gan&Lee Pharmaceuticals, Zealand Pharma	11-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Diamyd Medical AB Swiss Exchange

Equities

SE0005162880

Press Releases

Filters